您的购物车当前为空
别名 RPC-1063 hydrochloride, BMS-986374 hydrochloride
Ozanimod hydrochloride (RPC-1063 hydrochloride) 是一种可口服且具有选择性和高效性的鞘氨醇 1-磷酸 (S1P) 受体调节剂,对S1P1 和 S1P5显示出较高的亲和力。Ozanimod 具有潜在的抗癌活性,可用于研究复发性多发性硬化 (MS) 、溃疡性结肠炎、冠状病毒感染和骨髓增生。

Ozanimod hydrochloride (RPC-1063 hydrochloride) 是一种可口服且具有选择性和高效性的鞘氨醇 1-磷酸 (S1P) 受体调节剂,对S1P1 和 S1P5显示出较高的亲和力。Ozanimod 具有潜在的抗癌活性,可用于研究复发性多发性硬化 (MS) 、溃疡性结肠炎、冠状病毒感染和骨髓增生。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 328 | 现货 | |
| 5 mg | ¥ 826 | 现货 | |
| 10 mg | ¥ 1,190 | 现货 | |
| 25 mg | ¥ 1,970 | 现货 | |
| 50 mg | ¥ 3,360 | 现货 | |
| 100 mg | ¥ 4,790 | 现货 | |
| 200 mg | ¥ 6,660 | 现货 | |
| 1 mL x 10 mM (in DMSO) | ¥ 798 | 现货 |
Ozanimod hydrochloride 相关产品
| 产品描述 | Ozanimod hydrochloride (RPC-1063 hydrochloride) is an orally available, selective and potent sphingosine 1-phosphate (S1P) receptor modulator that shows high affinity for S1P1 and S1P5.Ozanimod has potential anticancer activity and can be used in the study of multiple sclerosis (MS), ulcerative multiple sclerosis (UMS), and other diseases. (MS), ulcerative colitis, coronavirus infections and myelodysplasia. |
| 靶点活性 | S1P1 receptor:1.03 nM (EC50), S1P5 receptor:8.6 nM (EC50) |
| 体外活性 | Ozanimod hydrochloride 作为一种鞘氨醇 1-磷酸 (S1P) 受体调节剂,以高亲和力选择性地结合 S1P 受体亚型1 (S1P1) 和 S1P5[1]。 |
| 体内活性 | 在实验性自身免疫性脑脊髓炎模型中,Ozanimod hydrochloride(0.05、0.2或1 mg/kg;口服灌胃;每日一次;连续 14 天)能减轻体重损失,末期疾病评分在 0.2 和 1 mg/kg 剂量组显著减轻,所有剂量组的细胞计数也显著降低[1]。 |
| 别名 | RPC-1063 hydrochloride, BMS-986374 hydrochloride |
| 分子量 | 440.92 |
| 分子式 | C23H25ClN4O3 |
| CAS No. | 1618636-37-5 |
| Smiles | N(CCO)[C@@H]1C=2C(=C(C=CC2)C=3N=C(ON3)C4=CC(C#N)=C(OC(C)C)C=C4)CC1.Cl |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 150 mg/mL (340.2 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (11.34 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容